Aspirin reduces risk of death by 47% in patients with new crown COVID-19 infection

A new study from the University of Maryland School of Medicine (UMSOM) shows that patients who take small doses of aspirin daily to prevent cardiovascular disease have a significantly lower risk of complications and death than those who do not.
: Patients taking aspirin were significantly less likely to be admitted to intensive care units (ICUs) or connected to mechanical ventilators than inpatients who did not take aspirin.
study involved 412 COVID-19 patients, who were on average 55 years old, who had been hospitalized in the past few months for complications of infection.
about a quarter of patients take low doses of aspirin (usually 81mg) daily before or after hospitalization to control cardiovascular disease.
researchers found that patients who took aspirin had a 44 percent lower risk of using a mechanical ventilator, a 43 percent lower risk of ICU hospitalization, and a 47 percent lower risk of dying in hospital than those who did not.
the risk of adverse events (e.g. haemorrhage) did not increase significantly during hospitalization in patients in the aspirin group.
photo sources: Aspirin Use Is Associated with Med Mechanical Developmenton, ICU Admission, and In-Hospital Mortality in Hospital Patients with COVID-19. 2020. Anesthesia and Analgesia.